Format

Send to

Choose Destination
Mov Disord. 2017 Jun;32(6):810-819. doi: 10.1002/mds.27022.

Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy.

Author information

1
Medical Research Council Brain Network Dynamics Unit at the University of Oxford, Oxford, UK.
2
Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
3
Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland.
4
Institute of Neurology, University College London, London, UK.

Abstract

Continuous high-frequency DBS is an established treatment for essential tremor and Parkinson's disease. Current developments focus on trying to widen the therapeutic window of DBS. Adaptive DBS (aDBS), where stimulation is dynamically controlled by feedback from biomarkers of pathological brain circuit activity, is one such development. Relevant biomarkers may be central, such as local field potential activity, or peripheral, such as inertial tremor data. Moreover, stimulation may be directed by the amplitude or the phase (timing) of the biomarker signal. In this review, we evaluate existing aDBS studies as proof-of-principle, discuss their limitations, most of which stem from their acute nature, and propose what is needed to take aDBS into a chronic setting. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

KEYWORDS:

Parkinson's disease; brain-computer interface; closed-loop; deep brain stimulation; essential tremor

PMID:
28597557
PMCID:
PMC5482397
DOI:
10.1002/mds.27022
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center